5191 completed, 1235 terminated, 1093 recruiting, 1039 unknown. 9940 Phase 2, 1879 Phase 1, 748 Phase 3.
Follow Urogenital Diseases: new trials by email Literature Review of Urogenital Diseases trials Research Report on Urogenital Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Naloxegol in the Prevention of POI After Cystectomy Naloxégol oxalate, Placebo oral tablet - Bladder Cancer, Cystostomy; Complications | Phase 2 | Withdrawn | Institut Paoli-Calmettes | 2032-01-01 | 2026-10-14 | |
| Device for Bladder Control for Men With SCI Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 12 | 2028-06-01 | 2026-06-25 |
| A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy 177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer | Phase 1 / Phase 2 | Not yet recruiting | CHU de Quebec-Universite Laval | 500 | 2028-03-01 | 2025-03-30 |
| Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) NM8074 - IgA Nephropathy | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 10 | 2028-02-01 | 2026-04-13 |
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Amino Acid Therapy Evaluating the Incidence of New-Onset AKI Amino Acid infusion, Lactated Ringer Solution - Acute Kidney Injury | Phase 2 | Not yet recruiting | Children's Hospital Medical Center, Cincinnati | 270 | 2027-10-01 | 2026-10-21 |
| Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome | Phase 2 / Phase 3 | Not yet recruiting | University of Massachusetts, Worcester | 226 | 2027-09-01 | 2026-09-28 |
| REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants REGN21353, Nezastomig, Sarilumab Prophylaxis (Contingency) - Metastatic Castration-Resistant Prostate Cancer, mCRPC | Phase 1 / Phase 2 | Not yet recruiting | Regeneron Pharmaceuticals | 192 | 2027-06-28 | 2026-09-30 |
| Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 16 | 2027-05-17 | 2026-10-21 |
| Breakthrough - T1DM and Chronic Kidney Disease Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease | Phase 1 / Phase 2 | Recruiting | University of Chicago | 10 | 2027-04-29 | 2026-08-20 |
| Topical Curcumin for HPV Related Cervical Disease Curcumin C3 Complex, Placebo - Neoplasm Cervix | Phase 2 | Not yet recruiting | Lisa Flowers | 200 | 2027-04-01 | 2026-05-08 |
| Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders Ravulizumab - Preeclampsia | Phase 2 | Recruiting | Mayo Clinic | 14 | 2027-04-01 | 2026-10-22 |
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH). TRA16, Placebo - Enteric Hyperoxaluria | Phase 2 | Not yet recruiting | Wuhan Kangfude Urolithiasis Research Institute Co., Ltd. | 30 | 2027-03-01 | 2026-10-13 |
| SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma Stereotactic Body Radiation Therapy (SBRT), Anlotinib, Bemarituzumab - Locally Advanced or Metastatic Renal Cell Carcinoma | Phase 2 | Not yet recruiting | Fujian Cancer Hospital | 27 | 2027-02-01 | 2026-10-01 |
| Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis) | Phase 2 | Not yet recruiting | Medical University of Vienna | 60 | 2027-02-01 | 2026-09-18 |
| Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer losartan, Paclitaxel - Platinum Resistant Ovarian Cancer | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 27 | 2027-02-01 | 2026-09-22 |
| Little Lungs Study Calfactant, Budesonide - Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome | Phase 1 / Phase 2 | Not yet recruiting | University of Wisconsin, Madison | 24 | 2027-02-01 | 2026-11-02 |
| Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis Bupropion Hydrochloride 150 MG - End Stage Renal Disease, Fatigue | Phase 1 / Phase 2 | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 16 | 2027-02-01 | 2026-11-02 |
Showing 20 of 9940. Sign in to see all of them.
Prostatic Neoplasms (1924) · Ovarian Neoplasms (1181) · HIV Infections (919) · Carcinoma, Renal Cell (816) · Uterine Cervical Neoplasms (569) · Urinary Bladder Neoplasms (522) · Endometrial Neoplasms (427) · Acquired Immunodeficiency Syndrome (418) · Fallopian Tube Neoplasms (381) · Renal Insufficiency, Chronic (363) · Kidney Neoplasms (340) · Carcinoma, Ovarian Epithelial (332) · Neoplasms (329) · Neoplasm Metastasis (297) · Kidney Failure, Chronic (273)
Female Urogenital Diseases and Pregnancy Complications (6473) · Genital Diseases (6169) · Female Urogenital Diseases (6030) · Male Urogenital Diseases (5758) · Neoplasms by Site (5468) · Neoplasms (5413) · Urogenital Neoplasms (5406) · Urologic Diseases (3401) · Genital Diseases, Female (2625) · Kidney Diseases (2335) · Genital Diseases, Male (2319) · Genital Neoplasms, Female (2107) · Pathological Conditions, Signs and Symptoms (2072) · Genital Neoplasms, Male (2048)
Carboplatin (351) · Paclitaxel (331) · Docetaxel (266) · pembrolizumab (260) · Cisplatin (255) · Bevacizumab (233) · Gemcitabine (232) · Prednisone (199) · Nivolumab (172) · Radiotherapy (152) · Magnetic Resonance Spectroscopy (139) · Cyclophosphamide (138) · enzalutamide (118) · Abiraterone Acetate (114) · Leuprolide (114)
National Cancer Institute (NCI) (408) · National Institute of Allergy and Infectious Diseases (NIAID) (303) · M.D. Anderson Cancer Center (173) · Memorial Sloan Kettering Cancer Center (134) · Novartis Pharmaceuticals (81) · Merck Sharp & Dohme LLC (77) · Mayo Clinic (76) · Gynecologic Oncology Group (75) · AstraZeneca (68) · GlaxoSmithKline (68) · Pfizer (66) · University of Washington (64) · University Health Network, Toronto (63) · Eli Lilly and Company (62) · Bayer (59)
United States (5384) · Canada (850) · China (824) · France (663) · United Kingdom (640) · Spain (609) · Germany (521) · Italy (519) · Australia (386) · Belgium (343) · Netherlands (318) · South Korea (318) · Poland (263) · Japan (221) · Denmark (210)
Robert J Amato, DO (17) · Alp Ikizler, MD (16)
PMID 37185961, PMID 39356039, PMID 36005278, PMID 40576086, PMID 38299639, PMID 37146227, PMID 31401903, PMID 32734597, PMID 33107592, PMID 39513526, PMID 33783815, PMID 35170751, PMID 35947046, PMID 37916745, PMID 41805697, PMID 37407274, PMID 41276263, PMID 19097774, PMID 27238653, PMID 28410911, PMID 32390133, PMID 34778952, PMID 35224732, PMID 37528520, PMID 38724717, PMID 40190112, PMID 40337980, PMID 40938675, PMID 41385299, PMID 19238149, PMID 23738544, PMID 25577718, PMID 32588430, PMID 32994091, PMID 33270906, PMID 34895272, PMID 36791280, PMID 36996264, PMID 37068952, PMID 37160401, PMID 37947276, PMID 38018702, PMID 38837240, PMID 39607014, PMID 40465397, PMID 41044356, PMID 22894553, PMID 22932804, PMID 23922302, PMID 24722180
2023 (81), 2016 (61), 2017 (57), U10CA027469 (57), 2009 (46), 2025 (45), U10CA180868 (44), 2008 (40), 2015 (39), 2018 (39), 2019 (39), 2014 (32), U10CA032102 (27), P30CA015704 (22), P30CA016672 (21)